Phyllis Gotlib Sells 3,706 Shares of American Well (NYSE:AMWL) Stock

Key Points

• Insider sale: Phyllis Gotlib sold 3,706 shares of AMWL on April 1 at an average price of $5.30 for $19,641.80, trimming her stake by 2.22% to 163,004 shares (worth ≈$863,921).
• Quarterly results: American Well reported Q4 EPS of ($1.52) that slightly beat estimates and revenue of $55.31M, but remains unprofitable with a -38.38% net margin and analysts forecasting a steep negative EPS for the year.
• Market and analyst view: The stock trades around $5.50 with a market cap of about $91M, and analysts mostly rate it a “Hold” (average target ~$7.42) amid recent price-target cuts and mixed ratings.

American Well Corporation (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 3,706 shares of the business's stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $5.30, for a total transaction of $19,641.80. Following the sale, the insider owned 163,004 shares of the company's stock, valued at approximately $863,921.20. This represents a 2.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Phyllis Gotlib also recently made the following trade(s):

• On Friday, January 2nd, Phyllis Gotlib sold 3,707 shares of American Well stock. The shares were sold at an average price of $4.85, for a total value of $17,978.95.

American Well Stock Performance

Shares of AMWL stock traded up $0.22 on Thursday, reaching $5.51. The stock had a trading volume of 22,215 shares, compared to its average volume of 92,324. The company has a 50 day simple moving average of $5.20 and a 200 day simple moving average of $5.09. American Well Corporation has a 1 year low of $3.71 and a 1 year high of $9.15. The stock has a market cap of $91.12 million, a P/E ratio of -0.93 and a beta of 1.34.

American Well (NYSE:AMWL - Get Free Report) last posted its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.59) by $0.07. American Well had a negative net margin of 38.38% and a negative return on equity of 35.33%. The company had revenue of $55.31 million for the quarter, compared to the consensus estimate of $52.71 million. On average, equities research analysts anticipate that American Well Corporation will post -9.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AMWL has been the topic of several analyst reports. Weiss Ratings reiterated a "sell (e+)" rating on shares of American Well in a research report on Wednesday, January 21st. Morgan Stanley reduced their price target on American Well from $10.50 to $6.00 and set an "equal weight" rating for the company in a research report on Thursday, December 18th. Stifel Nicolaus decreased their price objective on American Well from $6.00 to $5.00 and set a "hold" rating on the stock in a research note on Friday, February 13th. Finally, Wall Street Zen upgraded American Well from a "sell" rating to a "hold" rating in a research note on Sunday, March 22nd. One investment analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $7.42.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of AMWL. XTX Topco Ltd bought a new position in American Well in the 4th quarter worth $215,000. JPMorgan Chase & Co. raised its holdings in American Well by 16.5% during the second quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company's stock valued at $131,000 after acquiring an additional 2,081 shares during the period. Barclays PLC raised its holdings in American Well by 67.7% during the fourth quarter. Barclays PLC now owns 24,047 shares of the company's stock valued at $118,000 after acquiring an additional 9,705 shares during the period. Engineers Gate Manager LP purchased a new position in shares of American Well in the second quarter valued at about $101,000. Finally, Prelude Capital Management LLC purchased a new position in shares of American Well in the third quarter valued at about $86,000. Hedge funds and other institutional investors own 56.05% of the company's stock.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company's core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.